For research use only
| Cat No. | ABC-SC0071 |
| Product Type | Human Adult Stem Cells |
| Cell Type | Stem Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Brain |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human Neuronal Stem Cells; Frozen Vial and Plated cells are available.
HighQC™ Human Neuronal Stem Cells (hNSCs) are multipotent neural stem cells derived from human fetal neural tissue, capable of generating neurons, astrocytes, and oligodendrocytes under appropriate differentiation conditions. These cells typically exhibit bipolar or multipolar morphology and can be cultured as either adherent monolayers or neurospheres under defined growth conditions. They express hallmark hNSC markers such as Nestin and SOX2, which are crucial for self-renewal and multipotency, while lacking markers of terminal differentiation. HighQC™ hNSCs maintain stable proliferation over extended culture and exhibit neurogenic potential upon withdrawal of growth factors. Cytogenetic evaluation confirms a normal human karyotype with maintained genetic stability over serial expansion. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
| Product Code | HighQC™ Human Neuronal Stem Cell, Human NSC, hNSC, Human Neural Stem Cells |
| Species | Human |
| Cat.No | ABC-SC0071 |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Brain |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Adult Stem Cells |
HighQC™ hNSCs serve as an advanced in vitro model for studying human neurodevelopment, neural lineage specification, and central nervous system (CNS) disease mechanisms. Their ability to generate functional neurons and glial cells makes them ideal for modeling neurodegenerative disorders (e.g., Alzheimer’s, Parkinson’s), neural toxicity assays, and evaluating regenerative therapies. These cells are also well-suited for investigating mechanisms of traumatic brain injury, ischemia response, and cell-based CNS therapeutic strategies.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).